| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 20 | 2023 | 1176 | 3.550 |
Why?
|
| Muscular Atrophy | 14 | 2023 | 78 | 3.470 |
Why?
|
| Renal Insufficiency, Chronic | 15 | 2024 | 713 | 2.560 |
Why?
|
| Muscle Proteins | 9 | 2017 | 486 | 1.360 |
Why?
|
| Fibronectins | 3 | 2023 | 202 | 1.140 |
Why?
|
| rho-Associated Kinases | 3 | 2016 | 77 | 1.130 |
Why?
|
| Kidney | 11 | 2024 | 2102 | 1.010 |
Why?
|
| PTEN Phosphohydrolase | 7 | 2017 | 1011 | 0.830 |
Why?
|
| Forkhead Transcription Factors | 4 | 2017 | 762 | 0.830 |
Why?
|
| Denervation | 1 | 2022 | 35 | 0.810 |
Why?
|
| Cachexia | 3 | 2019 | 154 | 0.770 |
Why?
|
| Diabetes Mellitus, Experimental | 5 | 2022 | 212 | 0.690 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2017 | 221 | 0.640 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 4 | 2017 | 40 | 0.620 |
Why?
|
| Peritoneal Fibrosis | 3 | 2023 | 4 | 0.610 |
Why?
|
| Wasting Syndrome | 2 | 2017 | 21 | 0.600 |
Why?
|
| Mice, Inbred C57BL | 19 | 2024 | 7054 | 0.590 |
Why?
|
| Diabetic Nephropathies | 4 | 2023 | 175 | 0.590 |
Why?
|
| Muscle Fibers, Skeletal | 6 | 2018 | 115 | 0.570 |
Why?
|
| Mice | 38 | 2024 | 35421 | 0.550 |
Why?
|
| Triterpenes | 1 | 2016 | 68 | 0.540 |
Why?
|
| Animals | 48 | 2024 | 61363 | 0.520 |
Why?
|
| Podocytes | 3 | 2023 | 109 | 0.510 |
Why?
|
| Fibrosis | 10 | 2024 | 716 | 0.510 |
Why?
|
| Adipocytes | 1 | 2016 | 295 | 0.470 |
Why?
|
| Transcriptome | 2 | 2022 | 1960 | 0.460 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 377 | 0.450 |
Why?
|
| MicroRNAs | 5 | 2019 | 2884 | 0.430 |
Why?
|
| Acute Kidney Injury | 5 | 2020 | 758 | 0.430 |
Why?
|
| Insulin Resistance | 3 | 2016 | 720 | 0.420 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 617 | 0.410 |
Why?
|
| Sarcopenia | 1 | 2014 | 114 | 0.410 |
Why?
|
| Dietary Fats | 3 | 2012 | 340 | 0.410 |
Why?
|
| Proteolysis | 3 | 2018 | 378 | 0.380 |
Why?
|
| Peritoneal Dialysis | 2 | 2023 | 140 | 0.370 |
Why?
|
| Extracellular Vesicles | 2 | 2023 | 135 | 0.370 |
Why?
|
| Berberine | 1 | 2010 | 13 | 0.360 |
Why?
|
| Glucocorticoids | 3 | 2012 | 610 | 0.350 |
Why?
|
| Fibroblasts | 6 | 2023 | 1647 | 0.340 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2019 | 291 | 0.330 |
Why?
|
| Mitochondria | 1 | 2016 | 1293 | 0.330 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 310 | 0.330 |
Why?
|
| Cell Line | 11 | 2018 | 5313 | 0.330 |
Why?
|
| Insulin | 6 | 2022 | 1424 | 0.320 |
Why?
|
| Mice, Knockout | 13 | 2022 | 5692 | 0.310 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2020 | 39 | 0.300 |
Why?
|
| Proteasome Endopeptidase Complex | 6 | 2018 | 573 | 0.300 |
Why?
|
| Signal Transduction | 17 | 2019 | 12036 | 0.300 |
Why?
|
| Adipose Tissue, White | 2 | 2019 | 93 | 0.290 |
Why?
|
| Disease Models, Animal | 14 | 2020 | 7323 | 0.280 |
Why?
|
| Regeneration | 1 | 2010 | 284 | 0.280 |
Why?
|
| Ubiquitin | 5 | 2018 | 311 | 0.280 |
Why?
|
| Hypoglycemic Agents | 2 | 2010 | 601 | 0.270 |
Why?
|
| Aging | 1 | 2014 | 1531 | 0.260 |
Why?
|
| Reperfusion Injury | 3 | 2017 | 143 | 0.260 |
Why?
|
| Cells, Cultured | 9 | 2019 | 5658 | 0.250 |
Why?
|
| Tripartite Motif Proteins | 2 | 2017 | 46 | 0.250 |
Why?
|
| Energy Metabolism | 3 | 2017 | 985 | 0.240 |
Why?
|
| Forkhead Box Protein O1 | 2 | 2017 | 162 | 0.240 |
Why?
|
| Phosphatidylinositol 3-Kinases | 7 | 2023 | 1704 | 0.240 |
Why?
|
| Angiotensin II | 2 | 2020 | 193 | 0.240 |
Why?
|
| Duloxetine Hydrochloride | 1 | 2024 | 16 | 0.240 |
Why?
|
| Caspase 3 | 8 | 2015 | 460 | 0.240 |
Why?
|
| Adiponectin | 4 | 2013 | 142 | 0.240 |
Why?
|
| Myostatin | 2 | 2016 | 12 | 0.240 |
Why?
|
| Albuminuria | 4 | 2023 | 110 | 0.230 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2024 | 206 | 0.220 |
Why?
|
| Nephritis | 1 | 2024 | 41 | 0.220 |
Why?
|
| Endothelial Cells | 2 | 2022 | 1032 | 0.220 |
Why?
|
| Myoblasts, Skeletal | 2 | 2014 | 15 | 0.210 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2022 | 23 | 0.210 |
Why?
|
| Microtubule Proteins | 1 | 2022 | 43 | 0.210 |
Why?
|
| RNA, Small Nuclear | 1 | 2022 | 57 | 0.200 |
Why?
|
| Spleen | 1 | 2024 | 719 | 0.200 |
Why?
|
| Histone Deacetylases | 1 | 2024 | 362 | 0.190 |
Why?
|
| Antidepressive Agents | 1 | 2024 | 334 | 0.190 |
Why?
|
| Male | 25 | 2024 | 128522 | 0.190 |
Why?
|
| Phosphorylation | 9 | 2019 | 4905 | 0.190 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2010 | 131 | 0.190 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2020 | 14 | 0.180 |
Why?
|
| Myofibroblasts | 2 | 2020 | 93 | 0.180 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2017 | 866 | 0.180 |
Why?
|
| Cytokines | 6 | 2020 | 2804 | 0.180 |
Why?
|
| Hypertension | 2 | 2020 | 1584 | 0.180 |
Why?
|
| Desoxycorticosterone Acetate | 1 | 2020 | 1 | 0.180 |
Why?
|
| Gene Expression Regulation | 4 | 2023 | 4103 | 0.180 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2022 | 347 | 0.180 |
Why?
|
| Receptors, CXCR6 | 1 | 2020 | 16 | 0.180 |
Why?
|
| Transcription Factors | 4 | 2023 | 5416 | 0.170 |
Why?
|
| Dexamethasone | 2 | 2016 | 1525 | 0.160 |
Why?
|
| NF-kappa B | 4 | 2024 | 1555 | 0.160 |
Why?
|
| Myoblasts | 2 | 2010 | 62 | 0.160 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2019 | 188 | 0.160 |
Why?
|
| Muscle Cells | 2 | 2010 | 29 | 0.160 |
Why?
|
| Mice, Inbred Strains | 2 | 2010 | 556 | 0.150 |
Why?
|
| Chromatin | 1 | 2023 | 1043 | 0.150 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 60 | 0.150 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2017 | 27 | 0.150 |
Why?
|
| Protein Aggregates | 1 | 2017 | 26 | 0.150 |
Why?
|
| Glucose | 3 | 2022 | 1213 | 0.140 |
Why?
|
| Kidney Tubules | 1 | 2017 | 122 | 0.140 |
Why?
|
| STAT6 Transcription Factor | 1 | 2017 | 66 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 548 | 0.140 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2017 | 393 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 4 | 2014 | 616 | 0.140 |
Why?
|
| Adenosine Triphosphate | 2 | 2017 | 580 | 0.140 |
Why?
|
| Rats | 8 | 2016 | 6397 | 0.140 |
Why?
|
| Desoxycorticosterone | 1 | 2016 | 14 | 0.140 |
Why?
|
| Chemokine CXCL16 | 1 | 2016 | 11 | 0.140 |
Why?
|
| Enzyme Inhibitors | 2 | 2017 | 1944 | 0.140 |
Why?
|
| Hypertension, Renal | 1 | 2016 | 36 | 0.140 |
Why?
|
| Physical Conditioning, Animal | 1 | 2017 | 112 | 0.130 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 224 | 0.130 |
Why?
|
| Glycolysis | 1 | 2019 | 529 | 0.130 |
Why?
|
| Oxygen Consumption | 1 | 2017 | 418 | 0.130 |
Why?
|
| Thermogenesis | 1 | 2016 | 49 | 0.130 |
Why?
|
| Kidney Diseases | 2 | 2012 | 679 | 0.130 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 727 | 0.130 |
Why?
|
| Rats, Inbred F344 | 2 | 2014 | 235 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 7 | 2023 | 2050 | 0.130 |
Why?
|
| Adipose Tissue, Brown | 1 | 2016 | 110 | 0.130 |
Why?
|
| Mesangial Cells | 1 | 2015 | 7 | 0.130 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 337 | 0.130 |
Why?
|
| Mevalonic Acid | 1 | 2015 | 32 | 0.120 |
Why?
|
| Gene Expression | 4 | 2018 | 3606 | 0.120 |
Why?
|
| Muscles | 2 | 2007 | 443 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 1045 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2015 | 273 | 0.120 |
Why?
|
| Liver | 1 | 2024 | 3061 | 0.120 |
Why?
|
| Wnt3A Protein | 1 | 2014 | 24 | 0.120 |
Why?
|
| Blood Pressure | 2 | 2020 | 1555 | 0.120 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 27 | 0.120 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 305 | 0.110 |
Why?
|
| Recombinant Proteins | 2 | 2017 | 2986 | 0.110 |
Why?
|
| Metabolomics | 1 | 2017 | 504 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 294 | 0.110 |
Why?
|
| Nephrosclerosis | 1 | 2013 | 11 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 902 | 0.110 |
Why?
|
| Monocytes | 2 | 2017 | 784 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2015 | 293 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 3 | 2006 | 931 | 0.110 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 965 | 0.110 |
Why?
|
| Interleukin-6 | 4 | 2013 | 1032 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 986 | 0.100 |
Why?
|
| Transfection | 3 | 2012 | 3109 | 0.100 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2010 | 156 | 0.100 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2012 | 12 | 0.100 |
Why?
|
| Cisplatin | 1 | 2019 | 2509 | 0.100 |
Why?
|
| Gene Expression Profiling | 3 | 2022 | 5146 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2015 | 7233 | 0.100 |
Why?
|
| Electroporation | 1 | 2012 | 127 | 0.100 |
Why?
|
| Thiazolidinediones | 2 | 2010 | 147 | 0.100 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2010 | 160 | 0.100 |
Why?
|
| Cellular Senescence | 1 | 2014 | 389 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 4 | 2015 | 374 | 0.100 |
Why?
|
| Oligonucleotides | 1 | 2012 | 240 | 0.090 |
Why?
|
| Muscle Development | 1 | 2011 | 84 | 0.090 |
Why?
|
| Homeostasis | 1 | 2016 | 925 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2017 | 1626 | 0.090 |
Why?
|
| Brain | 1 | 2024 | 4199 | 0.090 |
Why?
|
| Cobra Cardiotoxin Proteins | 1 | 2010 | 6 | 0.090 |
Why?
|
| Vanadium Compounds | 1 | 2010 | 2 | 0.090 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 220 | 0.090 |
Why?
|
| Leukocytes | 1 | 2012 | 420 | 0.080 |
Why?
|
| Biomarkers | 2 | 2018 | 5050 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 4198 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2012 | 578 | 0.080 |
Why?
|
| Models, Biological | 1 | 2018 | 3187 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2014 | 2413 | 0.080 |
Why?
|
| Actins | 4 | 2017 | 586 | 0.080 |
Why?
|
| Serum Amyloid A Protein | 1 | 2009 | 39 | 0.080 |
Why?
|
| PPAR gamma | 1 | 2010 | 224 | 0.080 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2010 | 255 | 0.080 |
Why?
|
| Apoptosis | 6 | 2019 | 7757 | 0.080 |
Why?
|
| 3T3-L1 Cells | 3 | 2019 | 69 | 0.080 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2009 | 207 | 0.080 |
Why?
|
| DNA Primers | 1 | 2010 | 1489 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 1623 | 0.070 |
Why?
|
| Ghrelin | 1 | 2007 | 69 | 0.070 |
Why?
|
| Macrophages | 3 | 2020 | 1334 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 574 | 0.070 |
Why?
|
| Enzyme Activation | 4 | 2017 | 1801 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 3463 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2020 | 289 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2010 | 437 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 3205 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 402 | 0.070 |
Why?
|
| Body Weight | 2 | 2007 | 1282 | 0.070 |
Why?
|
| Receptor, Insulin | 1 | 2006 | 102 | 0.060 |
Why?
|
| Cell Division | 1 | 2010 | 2657 | 0.060 |
Why?
|
| RNA | 1 | 2010 | 1057 | 0.060 |
Why?
|
| Metabolic Diseases | 1 | 2006 | 140 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2010 | 1471 | 0.060 |
Why?
|
| Th2 Cells | 2 | 2017 | 245 | 0.060 |
Why?
|
| Myocardium | 1 | 2010 | 1180 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 3 | 2017 | 1754 | 0.060 |
Why?
|
| Ureteral Obstruction | 2 | 2017 | 141 | 0.060 |
Why?
|
| Humans | 17 | 2023 | 270809 | 0.060 |
Why?
|
| Time Factors | 3 | 2012 | 12979 | 0.060 |
Why?
|
| Obesity | 1 | 2016 | 2893 | 0.060 |
Why?
|
| Extracellular Matrix | 2 | 2017 | 523 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 216 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 4532 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2017 | 1458 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 256 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2007 | 704 | 0.050 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 395 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2005 | 258 | 0.050 |
Why?
|
| Caspases | 4 | 2006 | 672 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 920 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 123 | 0.050 |
Why?
|
| RNA, Messenger | 4 | 2022 | 6344 | 0.050 |
Why?
|
| Peritoneum | 1 | 2023 | 151 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 291 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 6639 | 0.050 |
Why?
|
| Myocytes, Cardiac | 2 | 2022 | 697 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2017 | 590 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 1155 | 0.050 |
Why?
|
| Chemokine CCL2 | 2 | 2013 | 193 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2023 | 172 | 0.050 |
Why?
|
| Heart Atria | 1 | 2023 | 345 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 3582 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2024 | 617 | 0.040 |
Why?
|
| Adipocytes, White | 1 | 2019 | 27 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2020 | 165 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 267 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 238 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2017 | 1254 | 0.040 |
Why?
|
| Inflammation | 2 | 2024 | 2491 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 2010 | 719 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2010 | 2139 | 0.040 |
Why?
|
| Cofilin 1 | 1 | 2017 | 15 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 146 | 0.040 |
Why?
|
| Autophagy | 1 | 2023 | 905 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2017 | 254 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 14639 | 0.030 |
Why?
|
| Gluconeogenesis | 1 | 2017 | 127 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 1536 | 0.030 |
Why?
|
| Cell Communication | 1 | 2019 | 509 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1072 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2017 | 317 | 0.030 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2016 | 15 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2015 | 1544 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2016 | 89 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 887 | 0.030 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2016 | 167 | 0.030 |
Why?
|
| Permeability | 1 | 2016 | 160 | 0.030 |
Why?
|
| Retinal Vessels | 1 | 2016 | 82 | 0.030 |
Why?
|
| Anthracenes | 1 | 2015 | 47 | 0.030 |
Why?
|
| Proteomics | 1 | 2023 | 1426 | 0.030 |
Why?
|
| Glomerular Mesangium | 1 | 2015 | 36 | 0.030 |
Why?
|
| Nephrectomy | 2 | 2012 | 793 | 0.030 |
Why?
|
| Collagen Type IV | 1 | 2015 | 106 | 0.030 |
Why?
|
| Folic Acid | 1 | 2017 | 370 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 3946 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2013 | 1571 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 186 | 0.030 |
Why?
|
| Ischemia | 1 | 2017 | 400 | 0.030 |
Why?
|
| Flavonoids | 1 | 2015 | 199 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 1683 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 344 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 1002 | 0.030 |
Why?
|
| Disease Progression | 2 | 2017 | 6881 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2013 | 32 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2016 | 4105 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2010 | 3567 | 0.030 |
Why?
|
| Cadherins | 1 | 2016 | 658 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2013 | 105 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 2419 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2013 | 84 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2019 | 1875 | 0.030 |
Why?
|
| CD11c Antigen | 1 | 2012 | 56 | 0.020 |
Why?
|
| YY1 Transcription Factor | 1 | 2011 | 17 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2012 | 82 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 7647 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2012 | 265 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 3472 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2016 | 1420 | 0.020 |
Why?
|
| Creatinine | 1 | 2013 | 525 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2015 | 2136 | 0.020 |
Why?
|
| Receptors, Angiotensin | 1 | 2009 | 45 | 0.020 |
Why?
|
| Imidazoles | 1 | 2015 | 1065 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 62 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2010 | 277 | 0.020 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2010 | 288 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2015 | 4966 | 0.020 |
Why?
|
| Pyridines | 1 | 2015 | 1312 | 0.020 |
Why?
|
| Receptors, Ghrelin | 1 | 2007 | 32 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 469 | 0.020 |
Why?
|
| Dactinomycin | 1 | 2007 | 162 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 1381 | 0.020 |
Why?
|
| Anilides | 1 | 2010 | 295 | 0.020 |
Why?
|
| Growth Hormone | 1 | 2007 | 215 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2007 | 234 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 5053 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2007 | 160 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 1825 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2011 | 1490 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 1152 | 0.020 |
Why?
|
| Eating | 1 | 2007 | 437 | 0.020 |
Why?
|
| Actomyosin | 1 | 2005 | 8 | 0.020 |
Why?
|
| Myofibrils | 1 | 2005 | 26 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 650 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2006 | 579 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 2087 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2004 | 116 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2015 | 2922 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 347 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 2478 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 3058 | 0.010 |
Why?
|
| Serine | 1 | 2004 | 390 | 0.010 |
Why?
|
| Plasmids | 1 | 2004 | 923 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2004 | 1250 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2006 | 1309 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 3656 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 15922 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 3328 | 0.010 |
Why?
|
| Adult | 1 | 2006 | 82074 | 0.000 |
Why?
|
| Middle Aged | 1 | 2006 | 90570 | 0.000 |
Why?
|
| Female | 1 | 2006 | 148940 | 0.000 |
Why?
|